About Mehilainen NEO
Hospital NEO is a private hospital situated in Turku and Salo, Finland that specializes in orthopedic day surgery and sport medicine. The hospital also focuses in high-quality aesthetic and plastic surgery. The hospital is privately owned.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Mehilainen NEO
During the past decade, Mehilainen NEO conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on
average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Mehilainen NEO
According to Clinical.Site data, the most researched conditions in "Mehilainen NEO" are
"Multiple Sclerosis" (2 trials), "Atopic Dermatitis" (1 trials), "Dermatitis, Atopic" (1 trials) and "Multiple Sclerosis, Relapsing-Remitting" (1 trials). Many other conditions were trialed in "Mehilainen NEO" in a lesser frequency.
Clinical Trials Intervention Types at Mehilainen NEO
Most popular intervention types in "Mehilainen NEO" are "Drug" (4 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Abrocitinib 200 mg" (2 trials), "Ocrelizumab" (2 trials), "Abrocitinib 100 mg" (1 trials), "Dupilumab 300 mg" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Mehilainen NEO
The vast majority of trials in "Mehilainen NEO" are
5 trials for "All" genders.
Clinical Trials Status at Mehilainen NEO
Currently, there are NaN active trials in "Mehilainen NEO".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Mehilainen NEO,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Mehilainen NEO, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".